Novel challenges associated with novel agents: the evolving scenario in renal cell carcinoma

被引：0
|
作者：
Di Lorenzo, Giuseppe [1 ]
Buonerba, Carlo [1 ]
机构：
[1] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Oncol Med, Naples, Italy
来源：
FUTURE ONCOLOGY | 2016年 / 12卷 / 03期
关键词：
cabozantinib; immunotherapy; kidney cancer; nivolumab; targeted therapy; PROSTATE-CANCER; PHASE-3; TRIAL; SIPULEUCEL-T; EVEROLIMUS; IMMUNOTHERAPY; NIVOLUMAB;
D O I：
10.2217/fon.15.328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [11] Novel kinase inhibitors in renal cell carcinoma: Progressive development of static agents
    Desai A.A.
    Stadler W.M.
    Current Oncology Reports, 2005, 7 (2) : 116 - 122
  • [12] Novel kinase inhibitors in renal cell carcinoma: Progressive development of static agents
    Desai A.A.
    Stadler W.M.
    Current Urology Reports, 2006, 7 (1) : 16 - 22
  • [13] Novel drugs for renal cell carcinoma
    Vakkalanka, Bhanu K.
    Bukowski, Ronald M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (10) : 1501 - 1516
  • [14] Novel imaging in renal cell carcinoma
    Krajewski, Katherine M.
    Shinagare, Atul B.
    CURRENT OPINION IN UROLOGY, 2016, 26 (05) : 388 - 395
  • [15] Novel therapies for renal cell carcinoma
    Fishman, M
    Seigne, J
    Antonia, S
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (06) : 1033 - 1044
  • [16] Novel drug for renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (1) : 6 - 6
  • [17] Identification of novel VHL targets that are associated with the development of renal cell carcinoma
    Abdulrahman, M.
    Maina, E. N.
    Morris, M. R.
    Zatyka, M.
    Raval, R. R.
    Banks, R. E.
    Wiesener, M. S.
    Richards, F. M.
    Johnson, C. M.
    Latif, F.
    Maher, E. R.
    ONCOGENE, 2007, 26 (11) : 1661 - 1672
  • [18] SPERM ASSOCIATED ANTIGEN 4 IS A NOVEL BIOMARKER FOR RENAL CELL CARCINOMA
    Shiraishi, Takumi
    Terada, Naoki
    Zeng, Yu
    Mooney, Steven
    Takahashi, Sayuri
    Takaha, Natsuki
    Miki, Tsuneharu
    Getzenberg, Robert
    Kulkarni, Prakash
    JOURNAL OF UROLOGY, 2012, 187 (04): : E177 - E178
  • [19] Identification of novel VHL targets that are associated with the development of renal cell carcinoma
    M Abdulrahman
    E N Maina
    M R Morris
    M Zatyka
    R R Raval
    R E Banks
    M S Wiesener
    F M Richards
    C M Johnson
    F Latif
    E R Maher
    Oncogene, 2007, 26 : 1661 - 1672
  • [20] Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapy
    Schmidinger, Manuela
    Zielinski, Christoph C.
    CANCER TREATMENT REVIEWS, 2009, 35 (03) : 289 - 296
12345